The two teams, composed of leading researchers from Canada and the UK with backing from the Canadian Institutes of Health Research and the UK Medical Research Council,will receive more than $7m over four years. They will be working to find new targets for antibacterial drugs and new ways to prevent or stop the spread of drug resistant infections in hospitals and other health care settings.

Dr Gary Dmitrienko (left) at the University Waterloo and Professor Tim Walsh (right) of the University of Cardiff will focus on hospital acquired infections with the aim of developing a new treatment for infections caused by bacteria resistant to beta-lactam antibiotics (eg. penicillin, carbapenems). (Funding: $3,565,700 over four years)

A team led by Dr Anthony Clarke  (left) of the University of Guelph and ProfessorChris Dowson (right)  of the University of Warwick will focus on increasing understanding of bacterial cell wall growth and production with the aim of identifying new targets for the development of new antibiotics. (Funding: $3,559,352 over four years)

"The UK Medical Research Council has made huge strides over the last century to stem the tide of bacterial infection", says (left)  Professor Doreen Cantrell, chair of the Immunity and Infections Board at the Medical Research Council.

"We must remain one step ahead of bacterial infections as they quickly learn how to combat drugs designed to beat them. We're hopeful that the Canada /UK Partnership on Antibiotic Resistance will add a new momentum to the work we have been carrying out in the UK and Canada."

FEEDSTUFF ANTIBIOTIC SPREADS RESISTANCE 
Researchers from Tufts University School of Medicine focus on the controversial, non-therapeutic use of antibiotics in food animals and fish farming as a cause of antibiotic resistance. They report that the preponderance of evidence argues for stricter regulation of the practice. 

World-renowned expert in antibiotic resistance, Stuart Levy,  (right) professor of molecular biology andmicrobiology and director of the Center for Adaptation Genetics and Drug Resistance at Tufts University School of Medicine, notes that a guiding tenet of public health, the precautionary principle, requires that steps be taken to avoid harm.

"The United States lags behind its European counterparts in establishing a ban on the use of antibiotics for growth promotion. For years it was believed that giving low-dose antibiotics via feed to promote growth in cows, swine, chickens and the use of antibiotics in fish farming had no negative consequences.

"Today, there is overwhelming evidence that non-therapeutic use of antibiotics contributes to antibiotic resistance, even if we do not understand all the mechanisms in the genetic transmission chain," he says.

For the past 70 years, humans have relied on antibiotics to combat bacterial infections such as streptococcus, meningitis, tuberculosis and urinary tract infections. The misuse and overuse of antibiotics, however, has contributed to antibiotic resistance, making antibiotics less effective at saving lives.

Levy and co-author Bonnie Marshall (left) summarise and synthesise the findings of a large number of studies assessing the link between antibiotic resistance and the use of non-therapeutic antibiotics in livestock and fish farming.

Highlights include the following:

•  According to estimates, antibiotics are eight times more likely to be used for non-therapeutic purposes than for treating a sick animal.

•  The long-term administration of antibiotics in animal feed creates an optimal environment for antibiotic resistance genes to multiply. Essentially, treated animals become "factories" for the production and distribution of antibiotic-resistant bacteria such as Salmonella and Methicillin-resistant Staphylococcus aureus (MRSA), a troubling infection that is resistant to common antibiotics. 

•  Bacteria can transfer antibiotic resistance to other bacteria, and multiple different resistance genes can be linked together in this process. Thus, even if farmers turn to antibiotics that are not commonly used to treat people, these drugs – given over long periods of time – can also promote resistance. Several studies demonstrated that antibiotic-resistant bacteria can easily spread from animals to people in close contact with animals, such as veterinarians, slaughterhouse workers, farmers, and the families of farmers.

•  As much as 90% of antibiotics given to livestock are excreted into the environment. Resistance spreads directly by contact and indirectly through the food chain, water, air, and manured and sludge-fertilised soils.

• The broad use of antibiotics in fish food in farm fishing, particularly overseas, leads to leaching where it can be washed to other sites, exposing wild fish to trace amounts of antibiotics.

•  According to the Centers for Disease Control and Prevention, antibiotic-resistant infections cause longer and more expensive hospital stays, and greater risk of death.

• Each year in the US antibiotic-resistant infections result in $20 billion in additional health care costs and $8 million in costs in additional hospital days. If antibiotics are ineffective, patients may end up paying more in search of alternative drugs, and enduring a wider range of side effects.

Bans diminish antibiotic resistance

• Bans in several European countries have led to decreases in antibiotic resistance. Bans in Denmark and Germany have not only decreased the presence of antibiotic-resistant bacteria in farm animals, they have decreased the presence of these bacteria in humans.

•  Alternative farming practices such as reducing animal crowding, improving hygiene, and improving use of vaccines have been shown to compensate for some of the growth benefits conferred by non-therapeutic antibiotics.

Levy and Marshall also highlight areas of study that may improve understanding of the link between antibiotic use in animals and the spread of antibiotic-resistant bacteria. Modern genetic techniques are helping, they report, but there are still gaps in our understanding at each stage of the transmission chain.

"Aquaculture, or fish farming, has been relatively understudied, yet water is a prime medium for the spread of antibiotic-resistant bacteria," says first author Bonnie Marshall, MA, MT (medical technology), senior research associate in the Levy laboratory at Tufts University School of Medicine.

"While the use of non-therapeutic antibiotics remains contentious, the evidence is strong enough to merit precaution. Antibiotics save lives. When infections become resistant to primary antibiotics, and alternative antibiotics must be used, health care costs increase. As more infections become more resistant to more antibiotics, we run the risk of losing more of our arsenal of antibiotics, resulting in needless deaths. It's important to consider what we stand to gain versus what we stand to lose," concludes Levy.

The Food & Drug Administration (FDA) has already taken some steps toward stricter regulation of non-therapeutic antibiotic use, acknowledging that the practice is in conflict with protecting the public health and proposing measures to limit the use of these drugs in animals.

Levy and his colleagues in the field of infectious disease have called for antibiotics to be classified by the FDA as "societal drugs," establishing specific regulations to protect the efficacy of the drugs.